PA
Perceptive Advisors’s Apogee Therapeutics APGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.3M | Buy |
1,182,148
+59,381
| +5% | +$2.58M | 1.9% | 12 |
|
|
2025
Q1 | $41.9M | Buy |
1,122,767
+75,535
| +7% | +$2.82M | 1.48% | 19 |
|
|
2024
Q4 | $47.4M | Sell |
1,047,232
-967,775
| -48% | -$43.8M | 1.31% | 24 |
|
|
2024
Q3 | $118M | Sell |
2,015,007
-90,629
| -4% | -$5.32M | 2.5% | 10 |
|
|
2024
Q2 | $82.9M | Buy |
2,105,636
+45,241
| +2% | +$1.78M | 2% | 12 |
|
|
2024
Q1 | $137M | Buy |
2,060,395
+232,494
| +13% | +$15.4M | 2.4% | 9 |
|
|
2023
Q4 | $51.1M | Hold |
1,827,901
| – | – | 1.14% | 28 |
|
|
2023
Q3 | $38.9M | Buy |
+1,827,901
| New | +$38.9M | 1.3% | 24 |
|